Home › Compare › MYMX vs RYLD

MYMX vs RYLD: Dividend Comparison 2026

MYMX yields 666666.67% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MYMX wins by $8.275235618773884e+34M in total portfolio value
10 years
MYMX
MYMX
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full MYMX calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — MYMX vs RYLD

📍 MYMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMYMXRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MYMX + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MYMX pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYMX
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, MYMX beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYMX + RYLD for your $10,000?

MYMX: 50%RYLD: 50%
100% RYLD50/50100% MYMX
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYMX buys
0
RYLD buys
0
No recent congressional trades found for MYMX or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMYMXRYLD
Forward yield666666.67% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.275235618773884e+34M$44.5K ✓
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓$2,587.35
Total dividends collected$8.275075881065991e+34M$18.8K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MYMX vs RYLD ($10,000, DRIP)

YearMYMX PortfolioMYMX Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,914$1,213.65+$66.67M → MYMX
2$415,506,651,117$415,435,306,334.37$14,099$1,351.30+$415506.64M → MYMX
3$2,419,908,598,386,268$2,419,464,006,269,573.00$16,580$1,494.55+$2419908598.37M → MYMX
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$19,384$1,642.61+$13171697643084.44M → MYMX
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$22,535$1,794.70+$67004927492790120.00M → MYMX
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$26,063$1,950.00+$318562277003514871808.00M → MYMX
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$29,995$2,107.69+$1.415484168853553e+24M → MYMX
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$34,361$2,266.99+$5.878130573362507e+27M → MYMX
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$39,194$2,427.12+$2.2813793009840744e+31M → MYMX
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$44,525$2,587.35+$8.275235618773884e+34M → MYMX

MYMX vs RYLD: Complete Analysis 2026

MYMX — Stock

Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

Full MYMX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this MYMX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYMX vs SCHDMYMX vs JEPIMYMX vs OMYMX vs KOMYMX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.